David MacPherson

6.5k total citations · 2 hit papers
48 papers, 4.3k citations indexed

About

David MacPherson is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, David MacPherson has authored 48 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 28 papers in Molecular Biology and 16 papers in Epidemiology. Recurrent topics in David MacPherson's work include Lung Cancer Research Studies (21 papers), Neuroendocrine Tumor Research Advances (14 papers) and Cancer-related Molecular Pathways (14 papers). David MacPherson is often cited by papers focused on Lung Cancer Research Studies (21 papers), Neuroendocrine Tumor Research Advances (14 papers) and Cancer-related Molecular Pathways (14 papers). David MacPherson collaborates with scholars based in United States, South Africa and United Kingdom. David MacPherson's co-authors include Tak W. Mak, Vuk Stambolic, Julien Sage, Brian J. Snow, Yunping Lin, Samuel Benchimol, Tyler Jacks, Adi F. Gazdar, Afshin Dowlati and Charles M. Rudin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Genes & Development.

In The Last Decade

David MacPherson

44 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of PTEN Transcription by p53

2001 753 citations Vuk Stambolic, David MacPherson et al. Molecular Cell profile →
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

2019 718 citations Charles M. Rudin, John T. Poirier et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David MacPherson United States	31	2.7k	2.4k	1.0k	693	498	48	4.3k
Vladimir Bezrookove United States	28	2.1k 0.8×	1.0k 0.4×	424 0.4×	724 1.0×	225 0.5×	48	3.3k
A. Hunter Shain United States	23	2.8k 1.0×	2.1k 0.9×	288 0.3×	1.2k 1.8×	571 1.1×	36	4.6k
Lyn M. Duncan United States	22	1.7k 0.6×	1.8k 0.7×	323 0.3×	686 1.0×	225 0.5×	41	3.3k
David W. Goodrich United States	34	3.1k 1.1×	2.3k 0.9×	244 0.2×	788 1.1×	1.1k 2.3×	97	5.0k
Akrit Sodhi United States	33	1.7k 0.6×	1.4k 0.6×	711 0.7×	740 1.1×	183 0.4×	64	4.3k
Makoto Saegusa Japan	38	1.8k 0.7×	1.3k 0.6×	484 0.5×	680 1.0×	565 1.1×	163	3.8k
Göran Jönsson Sweden	38	2.5k 0.9×	2.2k 0.9×	201 0.2×	1.2k 1.7×	630 1.3×	118	4.7k
Michael D. Hogarty United States	42	3.9k 1.4×	1.5k 0.6×	592 0.6×	2.3k 3.4×	345 0.7×	110	6.9k
Janice A. Royds United Kingdom	35	2.1k 0.8×	1.4k 0.6×	306 0.3×	682 1.0×	469 0.9×	100	3.7k
Patricia J.T.A. Groenen Netherlands	38	2.0k 0.7×	1.0k 0.4×	282 0.3×	376 0.5×	780 1.6×	129	4.3k

Countries citing papers authored by David MacPherson

Since Specialization

Citations

This map shows the geographic impact of David MacPherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David MacPherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David MacPherson more than expected).

Fields of papers citing papers by David MacPherson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David MacPherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David MacPherson. The network helps show where David MacPherson may publish in the future.

Co-authorship network of co-authors of David MacPherson

This figure shows the co-authorship network connecting the top 25 collaborators of David MacPherson. A scholar is included among the top collaborators of David MacPherson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David MacPherson. David MacPherson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Freie, Brian, Ali H. Ibrahim, Patrick A. Carroll, et al.. (2025). MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues. Science Advances. 11(17). eadt3177–eadt3177. 3 indexed citations

Hippe, Daniel S., Eli Grunblatt, Pritha Chanana, et al.. (2025). In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer. Science Advances. 11(17). eadq7084–eadq7084.

Hiatt, Joseph B., Anna-Lisa Doebley, Mohamed Adil, et al.. (2024). Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions. Science Advances. 10(15). eadk2082–eadk2082. 16 indexed citations

Oser, Matthew G., et al.. (2024). Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene. 43(7). 457–469. 18 indexed citations

Biswas, Sudipta, Kai Kang, Kwok Peng Ng, et al.. (2023). Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy. Cell Reports. 42(8). 113016–113016. 2 indexed citations

Hiatt, Joseph B., Sarah M. Garrison, Travis J. Friesen, et al.. (2022). Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing. Clinical Cancer Research. 28(20). 4551–4564. 68 indexed citations

Mathsyaraja, Haritha, Brian Freie, Emily Eastwood, et al.. (2021). Loss of MGA repression mediated by an atypical polycomb complex promotes tumor progression and invasiveness. eLife. 10. 24 indexed citations

Augert, Arnaud, Haritha Mathsyaraja, Ali H. Ibrahim, et al.. (2020). MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer. Cancer Cell. 38(1). 97–114.e7. 51 indexed citations

Corella, Alexandra, Ilsa M. Coleman, Jared M. Lucas, et al.. (2019). Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer. Clinical Cancer Research. 26(7). 1667–1677. 32 indexed citations

10.

Augert, Arnaud, Emily Eastwood, Ali H. Ibrahim, et al.. (2019). Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition. Science Signaling. 12(567). 154 indexed citations

11.

Rudin, Charles M., John T. Poirier, Lauren A. Byers, et al.. (2019). Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nature reviews. Cancer. 19(7). 415–415. 26 indexed citations

12.

Jia, Deshui, Arnaud Augert, Dong Wook Kim, et al.. (2018). Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition. Cancer Discovery. 8(11). 1422–1437. 115 indexed citations

13.

Gazdar, Adi F., Trisha K. Savage, Jane E. Johnson, et al.. (2015). The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung. Journal of Thoracic Oncology. 10(4). 553–564. 84 indexed citations

14.

Cui, Min, Arnaud Augert, Michael Rongione, et al.. (2014). PTEN Is a Potent Suppressor of Small Cell Lung Cancer. Molecular Cancer Research. 12(5). 654–659. 98 indexed citations

15.

MacPherson, David. (2008). Insights from mouse models into human retinoblastoma. Cell Division. 3(1). 9–9. 39 indexed citations

16.

MacPherson, David, Jungho Kim, Teresa S. Kim, et al.. (2004). Defective apoptosis and B‐cell lymphomas in mice with p53 point mutation at Ser 23. The EMBO Journal. 23(18). 3689–3699. 94 indexed citations

17.

MacPherson, David, Julien Sage, Denise Crowley, et al.. (2003). Conditional Mutation of Rb Causes Cell Cycle Defects without Apoptosis in the Central Nervous System. Molecular and Cellular Biology. 23(3). 1044–1053. 119 indexed citations

18.

Tsai, Kenneth Y., David MacPherson, Douglas A. Rubinson, et al.. (2002). ARF mutation accelerates pituitary tumor development in Rb +/− mice. Proceedings of the National Academy of Sciences. 99(26). 16865–16870. 35 indexed citations

19.

Stambolic, Vuk, David MacPherson, Yunping Lin, et al.. (2001). Regulation of PTEN Transcription by p53. Molecular Cell. 8(2). 317–325. 753 indexed citations breakdown →

20.

MacPherson, David, et al.. (1999). Primary adenoid squamous cell carcinoma of the upper lip associated with a locoregional metastasis: A case report and review of the literature. Journal of Oral and Maxillofacial Surgery. 57(5). 612–616. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact